ArticleFood and waterborne parasitology2019
Elevated incidence of alveolar echinococcosis in immunocompromised patients.
Article in Food and waterborne parasitology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 33 citations in OpenAlex.
- Long-Term Outcomes After Hepatectomy for Alveolar Echinococcosis in Immunosuppressed Patients.Pathogens (Basel, Switzerland) · 2026Article
- Increasing Case Numbers and Earlier Age at Diagnosis of Alveolar Echinococcosis: Insights from a 13-Year Retrospective Swiss Study.Pathogens (Basel, Switzerland) · 2026Observational
- Epidemiological and clinical characteristics of patients in the alveolar echinococcosis registry, France, 1982 to 2021.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025Article
- Human Alveolar Echinococcosis-A Neglected Zoonotic Disease Requiring Urgent Attention.International journal of molecular sciences · 2025Review
- TIM4+macrophages suppress the proinflammatory response to maintain the chronic alveolar echinococcosis infection.Frontiers in cellular and infection microbiology · 2025Article
- Alveolar echinococcosis in solid organ transplant recipients: a case series from two national cohorts.Parasite (Paris, France) · 2023Article
- A Rare Cause of Alveolar Echinococcal Metastasis.Revista da Sociedade Brasileira de Medicina Tropical · 2023Article
- Laparoscopic resection of hepatic alveolar echinococcosis: A single-center experience.PLoS neglected tropical diseases · 2022Article
- Primary Infection by E. multilocularis Induces Distinct Patterns of Cross Talk between Hepatic Natural Killer T Cells and Regulatory T Cells in Mice.Infection and immunity · 2022Article
- Initial Risk Assessment in Patients with Alveolar Echinococcosis-Results from a Retrospective Cohort Study.Pathogens (Basel, Switzerland) · 2022Article
- Characteristics and Clinical Course of Alveolar Echinococcosis in Patients with Immunosuppression-Associated Conditions: A Retrospective Cohort Study.Pathogens (Basel, Switzerland) · 2022Article
- Article
- Agranulocytosis leads to intestinalParasitology · 2021Article
- Combined cross-sectional and case-control study onVeterinary parasitology: X · 2020Article
- Fast-Growing Alveolar Echinococcosis Following Lung Transplantation.Pathogens (Basel, Switzerland) · 2020Article
- Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis.International journal for parasitology. Drugs and drug resistance · 2020Article
- Editorial overview: From farms and forests to forks? A review of diagnosis and management of globally important zoonoticFood and waterborne parasitology · 2019Article
Corrections and comments
- Erratum issued
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionRecent experimental data has revealed that the course of alveolar echinococcosis (AE) depends on adaptive immunity. For this study, we aimed to analyze the incidence and outcome of AE in immunocompromised humans. MATERIAL AND
methodsRetrospective analysis of 131 patients with a median age of 54 years treated for AE between 1971 and 2017 at a Swiss tertiary referral Centre. Fifty-two percent were females and 65 patients (50%) were diagnosed incidentally. Fourteen patients (16%) were operated on laparoscopically. Overall, median follow-up was 48 months.
resultsNew diagnoses have increased fourfold in immunocompetent and tenfold in immunocompromised patients in the past decade (
conclusionThe incidence of human AE has increased over the last 2 decades with surgical interventions resulting in excellent outcomes. We have observed an association of immunosuppressive conditions with both incidence and survival of AE eventually justifying the implementation of a screening program for patients at risk in endemic regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.